Send us a Message
Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
Search RGD Grant Resources Citing RGD About Us Contact Us
Genes Variants Community Projects QTLs Strains Markers Genome Information Ontologies Cell Lines References Download Submit Data
OntoMate (Literature Search) JBrowse (Genome Browser) Synteny Browser (VCMap) Variant Visualizer Multi-Ontology Enrichment (MOET) Gene-Ortholog Location Finder (GOLF) InterViewer (Protein-Protein Interactions) PhenoMiner (Quatitative Phenotypes) Gene Annotator OLGA (Gene List Generator) AllianceMine GViewer (Genome Viewer)
Aging & Age-Related Disease Behavioral & Substance Use Disorder Cancer & Neoplastic Disease Cardiovascular Disease Coronavirus Disease Developmental Disease Diabetes Hematologic Disease Immune & Inflammatory Disease Infectious Disease Liver Disease Neurological Disease Obesity & Metabolic Syndrome Renal Disease Respiratory Disease Sensory Organ Disease
Find Models Genetic Models Autism Models Rat PhenoMiner (Quantitative Phenotypes) Chinchilla PhenoMiner Expected Ranges (Quantitative Phenotype) PhenoMiner Term Comparison Hybrid Rat Diversity Panel Phenotypes Phenotypes in Other Animal Models Animal Husbandry Strain Medical Records Phylogenetics Strain Availability Calendar Rats 101 Submissions Photo Archive
Pathways
Rat Community Forum Directory of Rat Laboratories Video Tutorials News RGD Publications RGD Presentations Archive Nomenclature Guidelines Resource Links Laboratory Resources Employment Resources
Advanced Search (OLGA)

CLINICAL MEASUREMENT - ANNOTATIONS

The Clinical Measurement Ontology (CMO), Measurement Methods Ontology (MMO), and Experimental Condition Ontology (XCO) are currently being developed at the Rat Genome Database. For more information about these vocabularies please see Shimoyama et al. Three ontologies to define phenotype measurement data. Front Genet. 2012;3:87. Epub 2012 May 28 or contact us (https://rgd.mcw.edu/rgdweb/contact/contactus.html).
Term:cerebrovascular lesion incidence/prevalence measurement
go back to main search page
Accession:CMO:0002279 term browser browse the term
Definition:Any measurement in which the number of individuals in a study population that display cerebrovascular lesions at a point in time or develop cerebrovascular lesions within a determined period of time are compared to the total number of individuals in the study population. Often expressed as a percentage but could be expressed as a ratio. A cerebrovascular lesion is a non-tumorous, that is non-neoplastic, lesion of the brain which involves or is caused by a component of the vascular system and blood supply of the brain. These include strokes, any of a group of pathological conditions characterized by sudden, non-convulsive loss of neurological function due to brain ischemia and/or intracranial hemorrhages.
Synonyms:related_synonym: stroke incidence/prevalence measurement
 xref: MESH:D020521


show annotations for term's descendants           Sort by:
Term paths to the root
Path 1
Term Annotations click to browse term
  clinical measurement 236664
    disease population measurement 27
      disease incidence/prevalence measurement 27
        nervous system disease incidence/prevalence measurement 0
          cerebrovascular lesion incidence/prevalence measurement 0
            percentage of study population developing cerebrovascular lesions during a period of time + 0
            percentage of study population displaying cerebrovascular lesions at a point in time 0
Path 2
Term Annotations click to browse term
  clinical measurement 236664
    nervous system measurement 306
      central nervous system measurement 212
        brain measurement 155
          brain lesion measurement 0
            brain non-tumorous lesion measurement 0
              cerebrovascular lesion measurement 0
                cerebrovascular lesion incidence/prevalence measurement 0
                  percentage of study population developing cerebrovascular lesions during a period of time + 0
                  percentage of study population displaying cerebrovascular lesions at a point in time 0
paths to the root